Pfizer and BioNTech applies for an emergency use authorization from the U.S. Food and Drug Administration for their vaccine. If the application is approved, the vaccine will likely be limited and rolled out in phases.
Pfizer and BioNTech apply for an emergency use authorization from the U.S. Food and Drug Administration for their vaccine. If the application is approved, the vaccine will likely be limited and rolled out in phases.